CNS/Brain Cancer
From the Journals
Quality of life benefit exaggerated in some cancer studies
Conference Coverage
Collagen ‘tile’ delivers postsurgical radiation in glioblastoma
If replicated in larger trials, GT therapy “could define a new standard of care, and there would really be no reason why patients shouldn’t get...
From the Journals
Radiotherapy for brain metastases: ASTRO updates guidelines
“Modern management of brain metastases has become increasingly personalized, complex and multidisciplinary.”
Diminutio
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
Conference Coverage
Assay-guided chemo in recurrent glioma linked to longer survival
Patients fared better than when patients chose their treatment, although outcomes remain grim.
From the Journals
No link between cell phones and brain tumors in large U.K. study
“There is always a need for further research work, especially as phones, wireless, etc., become ubiquitous, but this study should allay many...
Latest News
Ways to lessen toxic effects of chemo in older adults
Three recent high-quality randomized trials evaluated the use of geriatric assessment in older adults with cancer.
From the Journals
Brain tumors exact higher mortality toll in men than women
“We cannot discount the role of sex differences in diagnosis, treatment, or behavioral risk factors that may underlie the better survival for...
Latest News
No link between mother’s pill use and CNS tumors in offspring
Exposure to sex hormones in utero is a recognized cause of cancer in affected offspring, and CNS tumors are increasingly more common in infants...
From the Journals
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
Observational study finds that antibiotics and glucocorticoids at 10 mg daily when given within 1 month before or after immune checkpoint...
Feature
Convenience, not outcomes may drive robot-assisted surgeries
The sale of robotically assisted surgical devices is expected to reach $14 billion by 2028. The technology is enticing to both surgeons and...